Is the Comeback Real — or Is It All Just an Illusion?
On Heels of Report Of Medical Errors, Biz Cooperates
Warning to Hospitals: Baby Boomers Are Coming!
First Major Ruling About Financial Incentives Upheld
Would IRP Make Plans Chirp Over Savings?
Plans' pharmacy costs to rise as much this year as in 1999
TennCare Brass Says There's Life After the Blues
Headlines on Deadline...
Some PCPs Are Worried Sick About Patients
Premium increases hitting double digits
Our other journal
P&T Journal for November 2014
LETTER TO THE EDITOR
Medications for Parkinson’s Disease
The Changing Roles of P&T Committees
Epilepsy Management: Newer Agents, Unmet Needs, and Future Treatment Strategies
Modest Growth Seen in Epilepsy Market
European Society of Cardiology and Transcatheter Cardiovascular Therapeutics
“Generic: The Unbranding of Modern Medicine,” by Jeremy A. Greene, MD, PhD
Misadministration of IV Insulin Associated With Dose Measurement And Hyperkalemia Treatment
FDA’s Proposed 503B Draft Compounding Guidance Raises Concerns of All Kinds
New Drugs/Drug News
Pharmaceutical Approval Update
Riociguat (Adempas): a Novel Agent For the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension